SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Fresh ESMO oncology updates are drawing attention, including early ovarian-cancer data for Lillys investigational Sofe-M combination; traders also debate the pullback and upcoming earnings, with bullish breakout hopes countered by concerns about fading momentum and resistance.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck and Modernas Phase 3 melanoma results for a personalized cancer vaccine added to Keytruda are the main focus, with the combination meeting recurrence-free and distant metastasis-free survival endpoints. Traders see the data as validation of Mercks oncology pipeline, while debating the vaccines broader potential, path to approval and commercial value against valuation concerns.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, range-bound trading, with repeated chart commentary describing consolidation. Holders see the pullback as a chance to accumulate or set up a rebound, while skeptics point to weak utility and worry about further declines.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention for its steep selloff toward 52-week lows, despite reported contract wins, analyst upgrades, and past earnings beats. Traders debate whether the decline reflects an expensive valuation, insider selling, and concerns about turning demand and production growth into profitsor an overdone pullback in a defense and drone company with long-term growth prospects.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the following segments: Materials and Magnetics. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

Chinas rare-earth export restrictions and uncertain U.S.-China negotiations have renewed attention on MPs role in building a domestic mine-to-magnet supply chain. Traders remain divided: some see geopolitical and government support as a long-term tailwind, while others focus on the stocks prolonged decline and question near-term execution and demand.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Traders are focused on CVSs November 4 earnings report, with many positioning for a rebound after the stocks recent pullback and pointing to technical support. Others are wary of sellers and whether the shares can regain momentum ahead of the results.

Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is drawing attention amid broad-market concerns about elevated rates, inflation, energy costs and a possible AI-led correction, with traders debating whether recent weakness signals deeper risk or a buying opportunity. Some favor long-term index investing and dollar-cost averaging, while others expect further volatility and declines.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is drawing attention around its earnings setup, with traders citing stronger engagement tied to the viral game Steal an Egg and analyst optimism about bookings. Bullish momentum and call positioning compete with caution about earnings volatility and the stocks history of sharp post-report moves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Attention centers on reports that the administration is weighing temporary access to certain compounded peptides, which traders view as a potential growth opportunity for Hims; no approval is confirmed. Optimism about peptides and a possible short squeeze contrasts with frustration over repeated reversals and resistance near $30.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellias FDA-accepted BLA for lonvo-z, granted Priority Review for hereditary angioedema, is the main catalyst, with traders focused on the March 2027 decision and the therapys Phase 3 results. Bulls see a potential path toward commercialization and validation of the gene-editing platform, while bears point to cash needs, commercialization risks and volatile trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Workday Prices $2.5 Bln Senior Notes Offering At Rates Of 5.700% To 6.500%

(RTTNews) - Workday, Inc. (WDAY), an enterprise cloud software company, on Wednesday announced that it has priced a $2.5 billion public offering of senior notes...

Workday Announces Pricing of $2.5 Billion Senior Notes Offering

Workday Announces Pricing of $2.5 Billion Senior Notes Offering Workday Announces Pricing of $2.5 Billion Senior Notes OfferingPR NewswirePLEASANTON, Calif., Oct. 21, 2026 PLEASANTON, Calif., Oct. 21, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ: WDAY), the trusted agentic platform for HR, finance...

Will Workday's C1.ai Acquisition Boost Its Enterprise AI Position?

WDAY's C1.ai acquisition aims to strengthen AI agent identity governance, enhance enterprise security and unlock growth opportunities amid rising AI adoption.

Workday (WDAY) Beats Stock Market Upswing: What Investors Need to Know

In the most recent trading session, Workday (WDAY) closed at $195.2, indicating a +2.3% shift from the previous trading day.

Workday Named a Leader in 2026 Gartner Magic Quadrant for Cloud ERP Finance

Workday Named a Leader in 2026 Gartner Magic Quadrant for Cloud ERP Finance Workday Named a Leader in 2026 Gartner Magic Quadrant for Cloud ERP FinancePR NewswirePLEASANTON, Calif., Oct. 19, 2026 PLEASANTON, Calif., Oct. 19, 2026 /PRNewswire/ -- Workday, Inc.(NASDAQ: WDAY), the trusted agentic...

Can WDAY's New AI Offerings Across Business Functions Drive Growth?

Workday introduces Decision Intelligence, an AI-powered platform that unifies workforce and financial data to help teams make faster, more informed decisions.



ServiceNow vs. Workday: Here's What Revenue Growth Trends Between These Software Companies Tell Investors

Key PointsServiceNow demonstrates stronger overall revenue generation than Workday, leading the comparison in every consecutive quarter over the last two years...

Deal Dispatch: Ithaca Holdings Buys Bumble for $1.3B, The Knot Acquires Zola, Character.ai Bankruptcy

Major M&A deals this week include Workday buys C1.ai, AKAM acquires Matthew Adam Properties, Getty Images considers bankruptcy.read more...

This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Analysts downgraded Varonis, Eastman Chemical, Workday and FMC; price targets fell for Eastman, Varonis and FMC.read more...

Yum! Brands Takes Over #272 Spot From Workday

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Yum! Brands Inc (Symbol: YUM) has taken over the #272 spot from Workday Inc (Symbol: WDAY), according to The Online Investor.

 Market capitalization is an important da...

Workday, Inc. engages in the development of enterprise cloud applications for finance and human resources. The firm delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. It operates through the Cloud Applications segment. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Workday Inc - Ordinary Shares - Class A

META, TTD, SNAP, GOOGL, BMBL, WDAY Stocks Get New UBS Targets Amid AI And Ad Shifts

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>UBS raised its price target on Meta to $884 from $715, citing opportunities to monetize AI-powered Business Agents and Muse.</li><li>The firm cut its Trade Desk target to $15 from $16, pointing to weaker ad budget allocation and competition from Amazon for advertiser spending.</li><li>It raised its price target on Snap to $7 but maintained a 'Neutral' rating, saying the platform has yet to benefit meaningfully from an improving digital advertising environment.</li></ul>UBS on Wednesday revised its price targets on six stocks spanning digital advertising, pointing to artificial intelligence (AI) monetization opportunities at Meta Platforms, intensifying competition for The Trade Desk (TTD) and uncertainty over Workday's (WDAY) longer-term growth prospects.The firm's latest assessments flagged the uneven recovery in digital advertising. While UBS sees opportunities for Meta to generate additional revenue through AI-powered tools and messaging platforms, it said advertisers were still not prioritizing Snap (SNAP) despite an improving industry backdrop.&nbsp;For Alphabet (GOOG, GOOGL), concerns about the impact of AI on Search and the prospect of advertising on ChatGPT have eased, though the bank sees few near-term catalysts.UBS also raised its target price for Bumble (BMBL) following the company's agreement to be acquired by Ithaca Holdings.<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col><col><col></colgroup><tbody><tr><td>Stock</td><td>UBS Price Target</td><td>Previous Target</td><td>Rating</td><td>Implied Upside</td></tr><tr><td>Meta Platforms (META)</td><td>$884</td><td>$715</td><td>Buy</td><td>15.90%</td></tr><tr><td>The Trade Desk (TTD)</td><td>$15</td><td>$16</td><td>Buy</td><td>23.30%</td></tr><tr><td>Snap (SNAP)</td><td>$7</td><td>$5.70</td><td>Neutral</td><td>7.90%</td></tr><tr><td>Alphabet (GOOGL)</td><td>$380</td><td>$379</td><td>Neutral</td><td>7.40%</td></tr><tr><td>Workday (WDAY)</td><td>$210</td><td>$220</td><td>Neutral</td><td>12.90%</td></tr><tr><td>Bumble (BMBL)</td><td>$6.05</td><td>$3</td><td>Neutral</td><td>1.70%</td></tr></tbody></table></figure></div>Source: Collated from investor notes on TheFly. Implied upside is calculated from each stock's closing price on Tuesday, Oct. 13, 2026, to UBS's revised price target.&nbsp;<h2 class="st-heading-2">Snap Struggles To Win Ad Dollars</h2>UBS raised its price target on Snap to $7 from $5.70 but maintained a 'Neutral' rating. The firm said advertisers were still not prioritizing the social media platform, even as the broader digital advertising environment improves.&nbsp;<a href="https://stocktwits.com/symbol/SNAP">SNAP stock</a> slipped 0.15% in premarket trading. Retail sentiment on Stocktwits shifted to ‘extremely bullish’ from ‘bullish’ territory over the past day. The stock has been on the rise for the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/snap-stock-sees-large-option-buying-on-longest-winning-streak-in-over-a-year/cZxInsdRB88">last six sessions</a>.On Meta, UBS raised its price target to $884 from $715, citing opportunities to develop additional AI-driven revenue streams. The firm sees the rollout of Business Agents and increasing use of Muse supporting monetization across WhatsApp and Messenger, alongside potential gains in search advertising share.&nbsp;Its advertising checks also point to strong incremental contributions from AI-driven automation and recommendations so far this year.<a href="https://stocktwits.com/symbol/META">META stock</a> fell 0.6% in premarket trading on Wednesday. Retail sentiment around the shares on Stocktwits remained in ‘bearish’ territory over the past day.<h2 class="st-heading-2">Amazon Competition Weighs On Trade Desk</h2>UBS cut its price target on The Trade Desk to $15 from $16. The firm said its lower target reflects concerns about weaker budget allocation and advertisers shifting spending toward Amazon (AMZN), which has been increasing its presence in digital advertising.<a href="https://stocktwits.com/symbol/TTD">TTD stock</a> rose 0.7% in premarket trading. Retail sentiment on Stocktwits moved to ‘neutral’ from ‘bullish’ territory over the past day.For Alphabet, UBS increased its target marginally to $380 from $379 and maintained a 'Neutral' rating. The target implies roughly 7% upside from Tuesday's closing price.&nbsp;The firm said that while concerns about the potential impact of advertising on ChatGPT and the integration of AI into Google's Search business have eased, it does not see a clear positive catalyst for the stock at present.<a href="https://stocktwits.com/symbol/GOOGL">GOOGL stock</a> gained 1.3% in pre-market trade. On Stocktwits, retail sentiment around the tech giant trended in ‘bullish’ territory over the past day.&nbsp;<h2 class="st-heading-2">Workday's Longer-Term Outlook In Focus</h2>UBS lowered its price target on Workday to $210 from $220, pointing to uncertainty about the company's longer-term growth trajectory. Workday reaffirmed its fiscal 2028 outlook in its latest earnings call, which calls for 11% revenue growth and 200 basis points of operating margin expansion.&nbsp;However, UBS said the absence of targets beyond fiscal 2028 leaves less visibility into its growth path. The firm also expressed a more cautious view of Workday's longer-term prospects relative to Salesforce (CRM) and ServiceNow (NOW). Its concerns include how AI could reshape the software industry and Workday's execution track record.<a href="https://stocktwits.com/symbol/WDAY">WDAY stock</a> edged 0.5% higher in premarket trade. Retail sentiment on Stocktwits around the shares shifted to ‘bullish’ from ‘neutral’ territory over the past day.Meanwhile, UBS raised its price target on Bumble to $6.05 from $3 following the company's agreement to be acquired by Ithaca Holdings for $6.05 per share in cash.&nbsp;The firm said it views the deal as validation of the strategic value of Bumble's brand and user base. It added that private ownership could also give the company greater flexibility to invest in product development and AI initiatives over the longer term.<a href="https://stocktwits.com/symbol/BMBL">BMBL stock</a> was little changed in premarket trade, with retail sentiment on Stocktwits moving to ‘bullish’ from ‘extremely bullish’ territory over the past day.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dan-ives-says-semiconductor-sell-off-is-way-overdone-nvda-mu-skhy-sndk-stocks/cZxBWE1RBoV">Dan Ives Says Semiconductor Sell-Off Is ‘Way Overdone’ As AI Spending Fears Rattle NVDA, MU, SKHY, SNDK</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Traders work on the floor of the New York Stock Exchange (NYSE) on September 29, 2026 in New York City. Stocks were down slightly in morning trading as high global fuel prices continue to be a drag on the economy. (Photo by Spencer Platt/Getty Images)

UBS on Wednesday revised its price targets on six stocks spanning digital advertising, pointing to artificial intelligence (AI) monetization opportunities at Meta Platforms, intensifying competition for The Trade Desk (TTD) and uncertainty over Workday's 

Trade Desk's Amazon Challenge, Workday's Growth Questions And Snap's Ad Woes Lead UBS Revisions 

UBS raised its price targets on Meta, Snap, Alphabet and Bumble while cutting its targets on Trade Desk and Workday.


Amazon.com Inc

Bumble Inc

Alphabet Inc Class A

Snap Inc

Trade Desk Inc

Workday Inc

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$209.99
Prev Close	$209.99
Open	$209.52
Dividend Yield	0.00%
50-Day Moving Average	$193.36
Beta	0.81
Avg. Volume	2.62M
PE Ratio	42.62

52-Week High	$244.26
52-Week Low	$110.36
Market Capitalization	$50.61B
EPS (Annual)	$2.58
Price to Book	7.83
Revenue Per Employee	$454,000.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

WDAY Fundamentals